According to the data mining, 10.26% of Mexican patients with breast or ovarian cancer carry PVs in BRCA1 and 3.19% in BRCA2. This suggests that a significant proportion of these cancers in Mexico may be linked to variations in these genes. This evidence concerns the gene BRCA2 and cancer.